Greetings From London
The topic was the crisis in Ukraine. Around the table was a money manager from a large, well-known firm, a currency trader from a famous investment bank and a connected journalist friend of mine...
View ArticleEnter Kafka… One Where Bugs Win (Animal and CIA Alike)
We enter the realm of Kafka, with mines full of paperwork, where reporters are compared to drunken drivers… and the winners are bugs, buggers and possibly China.
View ArticleAlert: Take profits on Qualcomm calls
Now you may sell to close your position, if you haven’t already, as I will consider this trade closed.
View ArticleTech Crash! Why the Broad Market Could Be Next…
The high-flying momentum stocks have fallen quite a bit this week, with the NASDAQ composite dropping a full 1% at the beginning of the week. But the real damage lies just beneath the surface. Greg...
View Article“No Great Tragedy”
Once more, with feeling: Why U.S. gas exports won’t do a thing to harm Russia. Plus… When cheap gets cheaper: Mayer lunches in London, talking Russian stocks
View ArticleDashing Lawmakers’ Hyperbolic Dreams
Once more, with feeling: Why U.S. gas exports won’t do a thing to harm Russia. Plus… When cheap gets cheaper: Mayer lunches in London, talking Russian stocks
View ArticleHow QE Simulates a Real Economic Recovery
After 2008, the "borrow and spend" US economy officially ended. Since then, US consumers have learned the value of "thrift"... whether they've wanted to or not. But is it a lesson that will stick? As...
View ArticleWelcome to Agora Financial’s FDA Trader!
Hello there, and welcome to Agora Financial’s FDA Trader! My name is Paul Mampilly. I’ll be your editor. Below, I share with you what I think to be the greatest wealth-building opportunity available to...
View Article5,430.48… The Gold Story of the Decade
5,430.48 is the number you should concentrate on today and for the next nine months. If you've been waiting for the next leg higher in precious metals, you'll want to keep an eye on those all-important...
View ArticleObama’s Secret Russian “Buy” Signal
Tensions continue to mount on the Crimean peninsula. And despite a flurry of speculation, no one knows for sure how it's going to play out. Unless, of course, you're the White House Press Secretary....
View ArticleInvest in a Real Estate Investment Trust That Doesn’t Own Real Estate
This month Neil introduces two companies that not only offer big regular payouts, but also pay bonus dividends. Plus a new sell recommendation for 72% gains and stocks that are selling at bargain prices.
View ArticleFLASH BUY: Your Exclusive PDUFA Booster Shot
Yesterday, you received your first view of our new FDA Trader service. Importantly, we outlined four special categories that make up our portfolio. Today, your exclusive recommendation falls into that...
View Article“Patrimonial Capitalism” and Your Life Savings
As if the “war on savers” weren’t bad enough, here comes the war on investors: The book you’ve never heard of that’s paving the way for a global wealth tax
View ArticleWhat ““The Most Important Economics Book of the Decade” Means to You
As if the “war on savers” weren’t bad enough, here comes the war on investors: The book you’ve never heard of that’s paving the way for a global wealth tax
View ArticleDepressing News for High-End “Happiness Stocks”
Money can't buy happiness... or so the saying goes. But it can buy plenty of things that directly contribute to your happiness. Of course, whether that means a new Prada bag or fifth of Jim Beam...
View ArticleSTORM Cast: Your Trading Questions, Answered
As promised, I'm dedicating today’s STORM Cast to answering your pressing trading questions.
View ArticleSTORM Cast: Your Trading Questions, Answered
As promised, I'm dedicating today’s STORM Cast to answering your pressing trading questions.
View ArticleMidWeek Outlook
Stock indexes settled today’s session under pressure. Whatever the media points to, be it: Russian anxiety, Asian market weakness, Yellen, the Fed, bank stress, a firmer US dollar, money moving back...
View ArticleFLASH BUY: Your Exclusive PDUFA Booster Shot, Part II
I told you yesterday that a major event was going to happen today for our first recommendation. I told you that this event is the release of briefing documents for an advisory committee or panel...
View ArticleGet Excited for the Biotech Bloodbath
After a massive run-up over the last few years, biotech stocks seemed to have hit a wall. And while a blowback in the biotech sector will be bad news for "stay and pray" investors, it could mean big...
View Article
